A detailed history of Norden Group LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Norden Group LLC holds 652,608 shares of ABT stock, worth $66.7 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
652,608
Previous 20,424 3095.3%
Holding current value
$66.7 Million
Previous $2.25 Billion 3199.56%
% of portfolio
0.83%
Previous 0.39%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

SELL
$109.52 - $120.96 $68.2 Million - $75.4 Million
-623,073 Reduced 95.47%
29,535 $3.36 Billion
Q1 2024

Apr 19, 2024

BUY
$109.52 - $120.96 $69.2 Million - $76.5 Million
632,184 Added 3095.3%
652,608 $74.2 Billion
Q4 2023

Feb 05, 2024

SELL
$90.19 - $110.4 $275,350 - $337,051
-3,053 Reduced 13.0%
20,424 $2.25 Billion
Q3 2023

Nov 06, 2023

BUY
$95.53 - $114.62 $2.24 Million - $2.69 Million
23,477 New
23,477 $2.27 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $179B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Norden Group LLC Portfolio

Follow Norden Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norden Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Norden Group LLC with notifications on news.